Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Maren Leifheit-Nestler

Has grant

Project leader for biological safety, S1

Hannover Medical School

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cell Biology Cell Biology professors in Germany

Recent Grants

Grant: Open

Pathogenic mechanisms and outcome in C3G and pIC-MPGN

Open Date: 2026-01-01

Close Date: 2029-01-01

Grant: Close

Cystinosis-associated myopathy

Open Date: 2024-05-01

Close Date: 2026-04-01

Grant: Close

Musclin in Cystinosis

Open Date: 2023-12-01

Close Date: 2025-12-01

Grant: Close

Musclin as a new marker for muscle health in cystinosis

Open Date: 2023-01-01

Close Date: 2023-12-01

Grant: Close

Mechanisms of Nephrotoxicity Associated with Inorganic Phosphates in the Diet

Open Date: 2021-01-01

Close Date: 2022-01-01

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Katrina Evers

University Children's Hospital Zurich

SWITZERLAND

View details

Dieter Haffner

Head of department

Hannover Medical School

GERMANY

View details

Peter Claus

Hannover Medical School

GERMANY

View details

Michael Föller

University of Hohenheim

GERMANY

View details

Dirk Schnabel

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maren Leifheit-Nestler

Research Interests

Explore related searches

Recent Grants

Articles (18)

Health-Related Quality of Life in Children with X-Linked Hypophosphatemia Treated with Burosumab: Real-World Data from a German-Swiss Study

Age- and sex-specific reference values for phosphate homeostasis parameters—fibroblast growth factor 23 and soluble Klotho

LMS-based continuous reference values for the myokine musclin in serum in children and adults.

Markers and regulators of osteoblast and osteoclast activity in children with X-linked hypophosphatemia treated with burosumab.

The calcimimetic etelcalcetide restores cardiac function in chronic hyperphosphatemia via calcium sensing receptor-cAMP activation.

Kidney Injury Urine Biomarker Normal Ranges in Children.

Markers of Mineral Metabolism in Children With CKD Stages 2 to 5D.

Office Blood Pressure and Obesity in Children with X-Linked Hypophosphatemia.

High Phosphate Load Induces De Novo Formation of Tertiary Lymphoid Structures in the Kidney.

Nanoengineered Calcium Receptors Coupled with Microscale Thermophoresis Enable Sensitive, Low-Volume Quantification of Calcium Ions in Complex Biological Fluids.

Growth hormone treatment associates with improved circulating anti-aging protein Klotho and reduced arterial stiffness in children with CKD.

Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD?

Cystinosis-Associated Metabolic Bone Disease Across Ages and CKD Stages 1 to 5D/T.

LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort.

LMS-Based Pediatric Reference Values for Parameters of Phosphate Homeostasis in the HARP Cohort.

Short‐term fasting of mice elevates circulating fibroblast growth factor 23 (<scp>FGF23</scp>)

Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia.

Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.

Collaborators (5)

Katrina Evers

Dieter Haffner

Peter Claus

Michael Föller

Dirk Schnabel

Make your next move.